First CAR T-Cell Therapy Approved for Mantle Cell Lymphoma
The Food and Drug Administration (FDA) has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel; Kite Pharma) for the treatment...
Early Data Show Investigational ChAdOx1 nCoV-19 Vaccine Safe, Immunogenic
Interim results from the phase 1/2 COV001 trial evaluating the vaccine candidate ChAdOx1 nCoV-19 (AZD1222) showed that vaccination led to strong...
FDA Panel Votes on Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma
The Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee voted in favor (12-0) of the approval of belantamab mafodotin...
Aducanumab BLA for Alzheimer Disease Submitted for FDA Review
Biogen has submitted its Biologics License Application (BLA) to the Food and Drug Administration (FDA) for aducanumab as a treatment of...
Phesgo Approval Allows for Faster Administration of Pertuzumab and Trastuzumab
The Food and Drug Administration (FDA) has approved Phesgo™ (pertuzumab, trastuzumab, hyaluronidase-zzxf; Genentech), in combination with...
Casimersen NDA Submitted for Duchenne Muscular Dystrophy
Sarepta Therapeutics has completed the submission of the casimersen (SRP-4045) New Drug Application (NDA) for the treatment of Duchenne muscular...
Zepzelca Approved for Metastatic Small Cell Lung Cancer
The Food and Drug Administration has approved Zepzelca™ (lurbinectedin; Jazz Pharmaceuticals) for the treatment of adult patients with...
Immunotherapy Regimen Approved for Hepatocellular Carcinoma
The Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab; Genentech) in combination with Avastin® (bevacizumab; Genentech)...




